ChemoCentryx
CCXI
#3578
Rank
NZ$6.83 B
Marketcap
NZ$95.04
Share price
0.00%
Change (1 day)
36.69%
Change (1 year)

Market capitalization of ChemoCentryx (CCXI.defunct)

Last known market cap: NZ$6.83 Billion

On November 25, 2022 ChemoCentryx had a market cap of NZ$6.83 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ChemoCentryx from 2012 to 2022

End of year Market Cap

Year Marketcap Change
2022NZ$5.88 B57.76%
2021NZ$3.73 B-37.15%
2020NZ$5.93 B67.9%
2019NZ$3.53 B329.36%
2018NZ$0.82 B101.65%
2017NZ$0.40 B-20%
2016NZ$0.51 B-2.34%
2015NZ$0.52 B38.08%
2014NZ$0.37 B25.33%
2013NZ$0.30 B-37.5%
2012NZ$0.48 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$1.190 T 17,313.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$285.48 B 4,076.83%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$924.77 B 13,429.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$430.75 B 6,202.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$67.44 B 886.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$602.60 B 8,716.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$219.71 B 3,114.47%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$175.00 B 2,460.33%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$83.67 B 1,124.21%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel